Skip to main content

3 Result(s)

within Eszter Regős Remove this filter

and

  1. Article

    Open Access

    Syndecan-1 in Liver Diseases

    Liver diseases such as liver cirrhosis, primary and metastatic liver cancers are still a major medical challenge. Syndecan-1 is one of the most important proteoglycans in the liver. Syndecan-1 is normally expr...

    Eszter Regős, Katalin Karászi, Andrea Reszegi, András Kiss… in Pathology & Oncology Research (2020)

    Download PDF (11303 KB) View Article

  2. No Access

    Article

    Chronic Hyperglycaemia Induced Alterations of Hepatic Stellate Cells Differ from the Effect of TGFB1, and Point toward Metabolic Stress

    The deleterious effect of hyperglycemia on the biology of the liver is supported by clinical evidence. It can promote the development of fatty liver, liver fibrosis, even liver cancer as complication of diabet...

    Katalin Kiss, Eszter Regős, Kristóf Rada, Gábor Firneisz… in Pathology & Oncology Research (2020)

  3. No Access

    Article

    Response of Hepatic Stellate Cells to TGFB1 Differs from the Response of Myofibroblasts. Decorin Protects against the Action of Growth Factor

    Regardless to the exact nature of damage, hepatic stellate cells (HSCs) and other non-parenchymal liver cells transform to activated myofibroblasts, synthesizing the accumulating extracellular matrix (ECM) pro...

    Alexandra Fullár, Gábor Firneisz, Eszter Regős… in Pathology & Oncology Research (2017)